<table class="naaccr-summary-table naaccr-borders">
  <tr>
    <th class="naaccr-summary-header naaccr-borders">Item #</th>
    <th class="naaccr-summary-header naaccr-borders">Length</th>
    <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
    <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
    <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
    <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
  </tr>
  <tr>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">3,882</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">NAACCR</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2018</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">18</td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
    <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
  </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.lnPositiveAxillaryLevel1To2<br/><br/>

<div class='content chap10-para-head'><strong>Description</strong></div>
<div class='content chap10-para'>
<p>This data item pertains to the number of positive ipsilateral level I and II axillary lymph nodes and intramammary lymph nodes based on pathological information.</p>

</div>

<div class='content chap10-para-head'><strong>Rationale</strong></div>
<div class='content chap10-para'>
<p>Lymph Nodes Positive Axillary Level I-II can be collected by the surveillance community for breast cancers. Prior to 2018, Breast SSF#3 was used for Lymph Nodes Positive Axillary Level I-II.</p>

</div>



<div class='content chap10-para'><p><strong>Codes</strong></p>
</div>
<table>
        <tr class='code-row'><td class='code-nbr'>00</td><td class='code-desc'>All ipsilateral axillary nodes examined negative</td></tr>
        <tr class='code-row'><td class='code-nbr'>01-99</td><td class='code-desc'>1 - 99 nodes positive  
 (Exact number of nodes positive)</td></tr>
        <tr class='code-row'><td class='code-nbr'>X1</td><td class='code-desc'>100 or more nodes positive</td></tr>
        <tr class='code-row'><td class='code-nbr'>X5</td><td class='code-desc'>Positive nodes, number unspecified</td></tr>
        <tr class='code-row'><td class='code-nbr'>X6</td><td class='code-desc'>Positive aspiration or needle core biopsy of lymph node(s)</td></tr>
        <tr class='code-row'><td class='code-nbr'>X8</td><td class='code-desc'>Not applicable: Information not collected for this case  
 (If this item is required by your standard setter, use of code X8 will result in an edit error.)</td></tr>
        <tr class='code-row'><td class='code-nbr'>X9</td><td class='code-desc'>Not documented in medical record  
 Level I-II axillary nodes not assessed or unknown if assessed</td></tr>
</table>

<div class='content chap10-para'>
<p>Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.</p>

</div>
